Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Salvador Martin Algarra"'
Autor:
Phuong Tran, Shailender Bhatia, Agustin Vega-Crespo, Adi Diab, Gabriel Abril-Rodriguez, Walter J. Urba, Anusha Kalbasi, Katie M. Campbell, F. Stephen Hodi, Valsamo Anagnostou, Michael J. Quist, Cristina Puig-Saus, Craig L. Slingluff, Jennifer Tsoi, Petra Ross-Macdonald, Catherine S. Grasso, Jedd D. Wolchok, Antoni Ribas, John B. A. G. Haanen, Drew M. Pardoll, Egmidio Medina, Christophe Martignier, Yeon Joo Kim, Suzanne L. Topalian, Daniel Sanghoon Shin, Salvador Martin Algarra, Davis Y. Torrejon, Victor E. Velculescu, Ameya Champhekar, Bartosz Chmielowski, William H. Sharfman, Megan Wind-Rotolo, Jason J. Luke, Douglas B. Johnson, Mykola Onyshchenko, Daniel E. Speiser
Publikováno v:
Cancer cell, vol 38, iss 4
Cancer Cell
Cancer cell, vol 39, iss 1
Cancer Cell
Cancer cell, vol 39, iss 1
SUMMARY: We analyze the transcriptome of baseline and on-therapy tumor biopsies from 101 patients with advanced melanoma treated with nivolumab (anti-PD-1) alone or combined with ipilimumab (anti-CTLA-4). We find that T cell infiltration and interfer
Autor:
Santiago Viteri, Jordi Bertran-Alamillo, Clara Mayo-de-las-Casas, Salvador Martin Algarra, Ana Drozdowskyj, Niki Karachaliou, Miguel F. Sanmamed, Carlos Alvarez, Miguel Angel Molina-Vila, Leticia De Mattos-Arruda, Núria Jordana-Ariza, Jose Luis Manzano, Eva Muñoz-Couselo, J.P. Berros, Javier Cortes, Rafael Rosell, Maria Gonzalez-Cao, Alvaro Gonzalez
Publikováno v:
Melanoma Research. 25:486-495
BRAFV600E is a unique molecular marker for metastatic melanoma, being the most frequent somatic point mutation in this malignancy. Detection of BRAFV600E in blood could have prognostic and predictive value and could be useful for monitoring response
Autor:
Karmele Mujika, Pablo Luna, Victoria Eugenia Castellón Rubio, Javier Pérez Altozano, María José Lecumberri Biurrun, Jose Luis Manzano, María Eugenia Ortega, Virtudes Soriano, José Antonio López Martín, Delvys Rodriguez-Abreu, Luis Antonio Fernandez-Morales, Salvador Martin Algarra, Jordi Rubió-Casadevall, Anabel Ballesteros, Almudena Garcia, Ivan Marquez-Rodas, Teresa Puértolas Hernández, María Rodríguez de la Borbolla Artacho, Ainara Soria, Enrique Espinosa Arranz, Javier Martínez, Alfonso Berrocal, José Miguel Jurado García, Isabel Palacio, Ovidio Fernández, Miguel-Ángel Berciano-Guerrero, Ana Arance
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Consejería de Sanidad de la Comunidad de Madrid
Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
The main objective of the study was to evaluate the efficacy and safety of dabrafenib alone or combined with trametinib for compassionate use in patients with metastatic melanoma.This retrospective, observational study involved 135 patients with unre
Autor:
J. Rodriguez, Javier Pardo, Angel Panizo, Salvador Martin Algarra, Jesús J. Sola, Maria D. Lozano
Publikováno v:
Diagnostic Cytopathology. 28:131-135
The diagnosis of gastrointestinal stromal tumors (GISTs) is generally established on histopathologic examination of surgical specimens. Fine-needle aspiration (FNA), performed under the guidance of ultrasound or computed tomography, is being used wit
Autor:
José Manuel Aramendía, Jose Manuel Ordoñez, Javier Aristu, Salvador Martin Algarra, Rafael Martínez Monje, Esteban Salgado, Maria Gonzalez Cao, Antonio Brugarolas
Publikováno v:
American Journal of Clinical Oncology. 25:480-484
The purpose of this study was to evaluate the efficacy and tolerance of combined irinotecan and vinorelbine in previously treated patients with stage IIIB and IV non-small-cell lung cancer (NSCLC). Thirty-three patients with NSCLC (7 stage IIIB and 2
Autor:
Antonio Brugarolas, C. Beltran, José Javier Aristu, M. Moreno, Salvador Martin Algarra, Joseba Rebollo, Ignacio Azinovic, Rafael Martínez-Monge, José María López-Picazo, Oscar A Fernández, José Manuel Aramendía
Publikováno v:
American Journal of Clinical Oncology. 25:347-353
Multidisciplinary treatment in high-risk breast cancer improves survival and local control. The feasibility and patterns of failure after several induction and high-dose consolidation regimens of chemotherapy were evaluated in this study. Between Nov
Autor:
Lorenzo Alonso, Enrique Espinosa, Alfonso Berrocal, Ana Arance, Javier Valdivia, Eva Muñoz, Salvador Martin Algarra, Virtudes Soriano, Pilar Lopez Criado, José Antonio López Martín
Publikováno v:
Melanoma Research
Ipilimumab, a fully human, recombinant, monoclonal antibody to cytotoxic T-lymphocyte antigen 4 improves overall survival (OS) in previously treated and untreated metastatic melanoma. This retrospective analysis reports data gathered by a questionnai
Autor:
José Ramón Azanza, Almudena Gomez-Guiu, Salvador Martin Algarra, Jose Luis Perez-Gracia, Anabel del Barrio, Miguel Angel Campanero, María J. Blanco Prieto, José María López-Picazo, Francisco Guillén Grima, Alfonso Gurpide, Belén Sádaba
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 2, p e89747 (2014)
PLoS ONE, Vol 9, Iss 2, p e89747 (2014)
Background Palonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never been studied, even t
Autor:
Ignacio Azinovic, Gerardo Zornoza, Manuel Santos, Salvador Martin Algarra, Voltas J, Lluís Escudé, José L. Hernández, Felipe A. Calvo
Publikováno v:
Radiotherapy and Oncology. 15:133-140
Intraoperative radiotherapy (IORT) is an attractive boosting modality in the combined treatment of recurrent and/or residual colorectal cancer. Twenty seven patients treated with IORT are analysed. Residual disease following resection of the primary